American Hospital Dubai has launched the Focal One HIFU Robotic System, establishing a new benchmark for precision patient care in the region's fight against prostate cancer.

The system employs High-intensity Focused Ultrasound (HIFU) technology to non-invasively target and eliminate cancerous tissue, marking a significant advancement over traditional treatment methods which often involve incisions or radiation exposure.

As the first private healthcare facility in the UAE to offer this cutting-edge technology, American Hospital Dubai enhances its reputation for excellence in robotic surgery.

The introduction of Focal One HIFU aligns with the hospital's mission to provide patients with the latest advancements in robotic medical care in the United Arab Emirates and the broader region.

Focal One HIFU offers numerous advantages for men diagnosed with localized prostate cancer, presenting an advanced treatment option that is less invasive compared to conventional methods.

The procedure leverages focused ultrasound energy to minimize the impact on urinary and sexual function, thereby preserving the patient's quality of life.

The noninvasive nature of the technology eliminates surgical scars and reduces recovery time, allowing for same-day hospital discharge and a swift return to normal activities.

Dr. Muhammad Elmussareh, the Director of Urology and Assistant Chief Quality Officer at American Hospital Dubai, stated that the Focal One HIFU system represents a significant evolution in prostate cancer treatment.

The combination of precision targeting with fewer side effects provides an effective therapy option that prioritizes long-term well-being for patients.

The Focal One HIFU system bolsters American Hospital Dubai’s Prostate Clinic, which is designed to serve as a comprehensive facility for diagnostics and treatments concerning prostate health.

The clinic promises rapid services, including same-day testing and diagnosis, alongside expedited consultations to create effective treatment plans.

The hospital also holds the distinction of being accredited as a Centre of Excellence in Robotic Surgery (COERS) by the US-based Surgical Review Corporation, making it the first private healthcare institution in the region to achieve this recognition.

Sherif Beshara, Group CEO of American Hospital Dubai, expressed enthusiasm about the introduction of the Focal One HIFU technology, emphasizing the hospital's commitment to integrating the latest medical advancements into patient care while emphasizing the importance of quality of life.